Related Experiment Video
Updated: Feb 28, 2026
Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
MACULAR DEGENERATION AND ASPIRIN USE
Kent W Small1, Christine A Garabetian, Fadi S Shaya
1*Macula and Retina Institute, Los Angeles and Glendale, California and †Molecular Insight Research Foundation, Los Angeles and Glendale, California.
Aspirin significantly reduces stroke and vascular death risks. While some studies suggest a possible link to worsening age-related macular degeneration (AMD), the cardiovascular benefits of aspirin outweigh these potential risks.
Area of Science:
- Cardiology
- Ophthalmology
- Pharmacology
Background:
- Aspirin is widely used for cardiovascular disease prevention.
- Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults.
Purpose of the Study:
- To evaluate the cardiovascular benefits of aspirin.
- To assess the risk of aspirin use exacerbating age-related macular degeneration (AMD).
Main Methods:
- A systematic review and meta-analysis of six cardiovascular trials (167,580 participants) and four ophthalmological studies (12,015 participants).
- Critical analysis of prospective randomized trials and ophthalmological data sets.
Main Results:
- Aspirin use was associated with a 32% reduction in nonfatal stroke risk and a 15% reduction in fatal vascular deaths.
- Ophthalmological studies indicated a potential, but not statistically significant, exacerbation of AMD with aspirin use.
Conclusions:
- The substantial cardiovascular benefits of aspirin, including reduced stroke and heart attack risk, outweigh the theoretical risks of AMD exacerbation.
- Current evidence suggests aspirin is beneficial for cardiovascular health, with potential AMD risks manageable through therapies like anti-VEGF.
Related Concept Videos
01:30Drug toxicity: Drug–Drug Interaction
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption